FDA Drug Application (206627) for HYSINGLA by PURDUE PHARMA LP

Back to FDA Applications sponsored by PURDUE PHARMA LP

Application Number206627
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYSINGLA
Active IngredientHYDROCODONE BITARTRATE

Active IngredientCount
List of drugs with Active Ingredient HYDROCODONE BITARTRATE45


Back to FDA Applications sponsored by PURDUE PHARMA LP